[Pathogenesis of hyperkinesis in children].
Pheylalanine metabolism was studied in 56 children with various forms of hyperkinesias. It was found that in the development of slow and fast hyperkinesias a certain role belongs to dihydroxyphenylalanine (DOPA). It is probable, that in patients with Turett's syndrome the synthesis of DOPA is increased while in patients the excretion of phenylacetylglutamine was found to be disturbed: it was decreased in the patients with the fast and increased in the children with the slow hyperkinesias. Phenylalanine load led to a lowering of the DOPA level in the patients with Turett's syndrome; an intensification of the synthesis of phenylacetylglutamine and diminution of the intensity of hyperkinesias. L-glutamine load resulted in detoxication of the toxic phenylalanine metabolites which inhibited the DOPA synthesis, as well as in a short-time increase in the phenylacetylglutamine excretion and a moderation of tonic hyperkinesias that manifested by athetosis and dystonia. All this points out that in the development of various forms of hyperkinesias a certain role belongs to amino acid metabolites.
D000293:Adolescent; D002547:Cerebral Palsy / Q000188:drug therapy / Q000652:urine; D002648:Child; D002675:Child, Preschool; D004422:Dystonia Musculorum Deformans / Q000652:urine; D005260:Female; D005973:Glutamine / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000652:urine; D006801:Humans; D006948:Hyperkinesis / Q000652:urine*; D008297:Male; D010648:Phenylacetates / Q000652:urine; D010649:Phenylalanine / Q000627:therapeutic use; D013981:Tic Disorders / Q000652:urine; D005879:Tourette Syndrome / Q000188:drug therapy / Q000652:urine
D010648:Phenylacetates; D005973:Glutamine; D010649:Phenylalanine
O patogeneze giperkinezov u deteĭ.